Piecing Together the Adrenal Cancer Puzzle.
Through an international collaboration, researchers have produced an extensive characterization of adrenocortical carcinoma, a rare endocrine cancer with limited treatment options. They found that the disease has three DNA methylation-driven subtypes with distinct clinical outcomes, and is prone to genomic instability.